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Abstract: 16 
Abnormal fetal testis development has been proposed to underlie common disorders of the male reproductive 17 
system such as cryptorchidism, hypospadias, reduced semen quality and testicular germ cell tumour, which 18 
are regarded as components of a ‘testicular dysgenesis syndrome’. The increasing trends and geographical 19 
variation in their incidence have been suggested to result from in utero exposure to environmental chemicals 20 
acting as endocrine disruptors. In rodents, the anogenital distance (AGD), measured from the anus to the base 21 
of genital tubercle, is a sensitive biomarker of androgen exposure during a critical embryonic window of testis 22 
development. In humans, several epidemiological studies have shown alterations in AGD associated with 23 
prenatal exposure to several chemicals with potential endocrine disrupting activity. However, the link between 24 
AGD and androgen exposure in humans is not well defined. This review focuses on the current evidence for 25 
such a relationship. As in rodents, a clear gender difference is detected during fetal development of the AGD 26 
in humans which is maintained thereafter. Reduced AGD in association with clinically relevant outcomes of 27 
potential environmental exposures, such as cryptorchidism or hypospadias, is in keeping with AGD as a 28 
marker of fetal testicular function. Furthermore, AGD may reflect variations in prenatal androgen exposure in 29 
healthy children as shorter AGD at birth is associated with reduced masculine play behaviour in preschool 30 
boys. Several studies provide evidence linking shorter AGD with lower fertility, semen quality and 31 
testosterone levels in selected groups of adults attending andrology clinics. Overall, the observational data in 32 
humans are consistent with experimental studies in animals and support the use of AGD as a biomarker of 33 
fetal androgen exposure. Future studies evaluating AGD in relation to reproductive hormones in both infants 34 
and adults, and to gene polymorphisms, will help to further delineate the effect of prenatal and postnatal 35 
androgen exposures on AGD.   36 
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Introduction: 37 
Links between disorders of male reproductive system, such as reduced semen quality and testicular germ cell 38 
tumour (TGCC), as well as genital abnormalities at birth, such as cryptorchidism and hypospadias, are well 39 
established (Skakkebaek et al., 2001). These observations led to the hypothesis of ‘testicular dysgenesis 40 
syndrome’ (TDS) which proposes that abnormal testis development during fetal life is an important 41 
mechanism underlying common disorders of the male reproductive tract which manifest during infancy or 42 
adult life (Skakkebaek et al., 2001). Experimental animal studies, which used anti-androgens to alter fetal 43 
testis development, provide a compelling model to support the hypothesis (Dean and Sharpe, 2013). Although 44 
TGCC, one component of TDS, has not been replicated in animal models, this is perhaps due to species 45 
specificity (Juul et al., 2014). Rare disorders of sex development (DSD) due to a primary defect in testis 46 
determination, androgen secretion or androgen action manifest phenotypic features of TDS, supporting the 47 
relevance of the TDS model in humans (Hughes et al., 2007). The early origins of male reproductive disorders 48 
hypothesis is of relevance to public health as environmental exposure to potential endocrine disruptors in 49 
utero have been proposed to explain the increasing trends in the incidence and their marked geographical 50 
variation (Acerini and Hughes, 2006; Hauser et al., 2015). Estimating the burden of prenatal exposure to 51 
potential endocrine disruptors is a challenge, as congenital disorders of the male reproductive tract are 52 
relatively rare and disturbed reproductive function is likely to manifest a long time after the chemical 53 
exposure. In economic terms, an estimated annual cost to the European Union of 15 billion Euro has been 54 
calculated for the consequences of male reproductive disorders (e.g., treatments for infertility, orchidopexies, 55 
testis cancer) using the ‘Intergovernmental Panel on Climate Change’ weight-of-evidence characterization 56 
model for probability of causation (Hauser et al., 2015). 57 
 58 
The anogenital distance (AGD) measured from the anus to the genital tubercle is a sensitive biomarker of 59 
prenatal androgen action in animals (McIntyre et al., 2001; Mylchreest et al., 2000; Wolf et al., 2004). AGD 60 
signifies perineal growth and androgen-dependent caudal migration of the genital tubercle in rodents 61 
(Bowman et al., 2003). It is influenced by exposure to anti-androgens during a critical period of testis 62 
development known as the ‘masculinisation programming window’ (MPW) (van den Driesche et al., 2012; 63 
Welsh et al., 2008). Consequently, measurement of AGD has been used to study the effects of prenatal 64 
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exposure to a variety of chemicals with potential endocrine disrupting activity. Several epidemiological 65 
studies have shown reduced AGD in association with exposure to phthalates (Adibi et al., 2015; Bornehag et 66 
al., 2015; Suzuki et al., 2012; Swan et al., 2005), dioxins (Vafeiadi et al., 2013), bisphenol A (Miao et al., 67 
2011) and high fat diet (Papadopoulou et al., 2013), the latter indicative of organic pollutant exposure. It is not 68 
possible to conduct experimental toxicological studies in humans and therefore, the evidence for a causal 69 
effect of prenatal androgen exposure on AGD in humans is indirect (Welsh et al., 2007). This review focuses 70 
on the evidence linking AGD and androgen exposure in humans. 71 
 72 
Physiological aspects of androgen exposure in the male  73 
Leydig cells differentiate at approximately 8 weeks of gestation and secrete testosterone to mediate 74 
differentiation of the internal and external genitalia (Grinspon et al., 2014). Testosterone production is initially 75 
regulated during the first trimester by human chorionic gonadotrophin (hCG), which reaches a peak 76 
concentration at 12-17 weeks and subsequently declines (Cole, 2010). Development of the male genitalia is 77 
completed by 14-16 weeks (Grinspon et al., 2014; Welsh et al., 2008). Fetal luteinising hormone (LH) 78 
regulates testosterone secretion from the second trimester which induces further growth of the phallus and 79 
scrotum, and together with insulin-like factor 3 ( INSL-3), promotes testis descent (Asa et al., 1991; Bay et al., 80 
2007). After a surge of LH and testosterone secretion following delivery, testosterone levels decline in the 81 
first week of life (Corbier et al., 1990). Further activation of the hypothalamic-pituitary-gonadal axis known 82 
as the mini-puberty, starts at the end of the first week, peaking at 1-3 months of age before declining to low or 83 
undetectable levels by 6 months of age (Bergada et al., 2006; Forest et al., 1974; Kuiri-Hanninen et al., 2014). 84 
Subsequently, the axis remains quiescent until the onset of puberty. The observation of a MPW in the rat 85 
(equivalent to 8-14 weeks of gestation in the human) suggests that alterations in androgen action during a 86 
critical window of fetal development results in TDS and permanent changes in AGD (Welsh et al., 2008).  87 
 88 
Definition and measurement methods 89 
In rodents, AGD is measured from the anus to the posterior base of the genital tubercle (Gallavan et al., 1999). 90 
In contrast to rodents, the external genitalia are well developed at birth in humans with the genital tubercle 91 
transformed into the penis in males and clitoris in females. Investigators have used different landmarks to 92 
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measure AGD in humans to replicate the measurement in rodents. In males, AGD has been measured from the 93 
anus to the perineoscrotal junction (anoscrotal distance) (Salazar-Martinez et al., 2004), to the posterior base 94 
or to the anterior base of the penis (Hsieh et al., 2008) (Fig.1). Measurements in females use the distance from 95 
the anus to the anterior fourchette (anofourchettal distance) (Salazar-Martinez et al., 2004) or to the base of 96 
the clitoris (anoclitoral distance) (Liu et al., 2014). The method described by Salazar-Martinez et al. is 97 
commonly used; it is more reliable and has a lower inter-observer variability (Dean and Sharpe, 2013; 98 
Papadopoulou et al., 2013; Salazar-Martinez et al., 2004). In this review, the term AGD describes ‘anoscrotal 99 
distance’ in males and ‘anofourchettal distance’ in females unless otherwise stated (Salazar-Martinez et al., 100 
2004). Although AGD has been widely used as a marker of potential endocrine disruption in utero, its 101 
limitations include a lack of standardisation of methodology and information on reproducibility (Table-1) and 102 
insufficient data on normative references, including ethnic differences (Dean and Sharpe, 2013). AGD is 103 
associated with birth weight to a varying degree depending on the population studied (regression coefficient 104 
adjusted for gestation ranges from 1.5 to 3.0 mm/kg) (Papadopoulou et al., 2013; Romano-Riquer et al., 2007; 105 
Salazar-Martinez et al., 2004) and there is no consensus for adjusting AGD for the variations in body size. In 106 
addition, low birth weight is itself a risk factor for TDS as it is associated with hypospadias, cryptorchidism, 107 
male infertility and TGCC (Francois et al., 1997; Juul et al., 2014; Michos et al., 2007; Toppari et al., 2010).  108 
 109 
Fig. 1 110 
Table -1 111 
 112 
Associations between AGD, gender and age in healthy individuals 113 
The AGD in rodents is approximately twice as long in males compared to females, and is routinely used to 114 
determine sex (Dean and Sharpe, 2013). We and others have reported that AGD is also sexually dimorphic in 115 
humans and displays a similar relative magnitude of difference (male: female ratio ranges from 1.4:1 to 2.2:1) 116 
(Table-1) (Huang et al., 2008; Papadopoulou et al., 2013; Salazar-Martinez et al., 2004; Sathyanarayana et al., 117 
2010; Sathyanarayana et al., 2015; Thankamony et al., 2009). The sexual dimorphism is already present by 118 
gestation 11-13 weeks based on fetal imaging and, by weeks 17-20, it is of the same magnitude as that 119 
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observed at birth, with a male: female ratio of 2:1 (Fowler et al., 2011). The latter time point corresponds to 120 
the completion of differentiation of the external genitalia in humans (Welsh et al., 2008).  121 
A large cohort (n=925) from the Cambridge Birth Growth Study (CBGS) had AGD measurements performed 122 
at birth and at ages 3, 12, 18 and 24 months (Thankamony et al., 2009). AGD increased rapidly during the first 123 
3 months and plateaued after 1 year of age (Fig. 2). Using longitudinal and cross-sectional data from two birth 124 
cohorts in Greece and Spain, Papadopoulou et al. confirmed this pattern of growth. The sex dimorphism was 125 
maintained throughout to a similar degree to that observed at birth (male: female ratio; at birth, 2.2:1; age 24 126 
months; 2.3:1) (Thankamony et al., 2009). The similar proportional increase in AGD in boys and girls during 127 
the first two years suggests the growth of perineum in proportion to overall body size. However, the period of 128 
rapid increase in AGD and penile length during the first three months of life corresponds to the mini-puberty 129 
(Kurtoglu and Bastug, 2014). We also found a modest association between increments in AGD and penile 130 
length during this period independent of the changes in body size, suggesting the postnatal surge in 131 
testosterone production may also contribute to changes in AGD (Thankamony et al., 2009). A positive 132 
association has been found between penile growth and serum testosterone levels during the first three months 133 
of life (Boas et al., 2006). This observation, coupled with animal data showing changes in AGD when 134 
postnatal androgen exposure is altered (Mitchell et al., 2015), supports the hypothesis that the mini-puberty 135 
plays a part in postnatal AGD development. Further studies are needed to delineate mini-puberty and its AGD 136 
component using detailed anthropometry, as well as more frequent hormone measurements which may require 137 
novel methods such as dried blood spot analytical technology (McDade et al., 2007).  138 
 139 
Fig. 2 140 
 141 
Longitudinal data for AGD measurements from infancy to adulthood are not available. However, cross-142 
sectional data in young adults show that large increases occur in later life and sexual dimorphism is 143 
maintained to a lesser degree (ranges; males, 48.3 - 51.3 mm; females, 34.8 - 37.7 mm; male: female ratio 144 
calculated from the means from different studies, 1.4:1) (Lee et al., 2015; Mendiola et al., 2012; Mendiola et 145 
al., 2011; Parra et al., 2015). When these changes occur is not known. We speculate that large increases in 146 
AGD occur during puberty in association with the development of the external genitalia. AGD remain 147 
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unchanged in adult males, however, there are data to suggest that AGD decreases in females following the 148 
menopause (Eisenberg et al., 2013; Lee et al., 2015). 149 
 150 
Cryptorchidism and hypospadias 151 
Cryptorchidism and hypospadias are the most common genital anomalies at birth with incidences of 2-9% and 152 
0.2-1%, respectively, and provide an important outcome for studies of prenatal exposure to endocrine 153 
disrupting chemicals (Toppari et al., 2010). Establishing the relationship between AGD and congenital 154 
anomalies of the male reproductive tract at birth is key to determining whether AGD has a role as a biomarker 155 
of such prenatal exposure (Thankamony et al., 2014). A cross-sectional population study reported that boys 156 
with cryptorchidism have a shorter age-adjusted ‘anogenital index’ (a derivative of AGD adjusted for weight) 157 
(Swan et al., 2005). In boys undergoing surgery for hypospadias (n=26), AGD was measured under 158 
anaesthesia and found to be shorter compared with age-matched controls who had other urological conditions 159 
(Hsieh et al., 2012). In a larger study, we compared boys aged up to two years with cryptorchidism (n=71) or 160 
hypospadias (n=81) referred for surgical treatment with healthy controls from a birth cohort (n=482) by 161 
deriving age-specific standard deviation scores (SDS) of AGD and penile length (Thankamony et al., 2014). 162 
AGD measurements in boys with cryptorchidism (-0.48 SDS) or hypospadias (-0.90 SDS) were significantly 163 
lower compared with healthy controls (+0.03 SDS) (Fig. 3 & 4). They also had a shorter penile length 164 
(cryptorchidism, -0.35 SDS; hypospadias, -1.34 SDS) compared with healthy boys (-0.02 SDS). Boys with 165 
hypospadias also had smaller overall body size than controls, consistent with the well-documented prevalence 166 
of low birth weight in idiopathic hypospadias (Jensen et al., 2012). However, the reduction in AGD and penile 167 
length persisted following adjustment for body size in a multiple regression model. The observations of 168 
reduced AGD have also been reported in a large population-based study (boys with cryptorchidism, n=51; 169 
controls, n=534) from India involving consecutively born term male neonates evaluated at birth (Jain and 170 
Singal, 2013).  171 
 172 
Fig. 3 173 
Fig. 4 174 
 175 
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Hypospadias and cryptorchidism are relevant clinical disorders to evaluate the possible role of endocrine 176 
disruption, for which there is ample evidence from animal studies (van den Driesche et al., 2012; Welsh et al., 177 
2008). The evidence to support a link between these disorders and altered testis function in utero in humans 178 
relies on epidemiological studies (Toppari et al., 2010). These common disorders are sometimes the 179 
manifestations of rare, but, well-defined disorders of androgen production or action such as androgen receptor 180 
mutations. However, in the majority of cases the cause is unknown (Toppari et al., 2010). The link between 181 
reduced semen quality and TGCC (Skakkebaek et al., 2001), and the association between cryptorchidism and 182 
lower INSL3 or higher gonadotrophin levels (Bay et al., 2007; Suomi et al., 2006), attest to underlying testis 183 
dysfunction. Cryptorchidism is considered to be the result of a milder defect in androgen function as most of 184 
the cases are due to impaired inguinoscrotal descent which normally occurs between 26 and 40 weeks of 185 
gestation, compared with hypospadias which occurs earlier during the MPW (between 8 and 20 weeks) 186 
(Thorup et al., 2010). Reported trends towards a shorter AGD and penile length with increasing severity of 187 
hypospadias (Thankamony et al., 2014), and higher testis position in cryptorchidism (Jain and Singal, 2013), 188 
further suggest that AGD is a marker of the severity of impairments in androgen production. It is now 189 
recognised that approximately half of all cases of cryptorchidism are “acquired” (i.e. following normal 190 
positioning of the testes at birth), hitherto referred to as ‘the ascending testis’ (Hack et al., 2012). It is possible 191 
that this form of cryptorchidism may be associated with suboptimal testosterone production during mini-192 
puberty (Acerini et al., 2009; Wohlfahrt-Veje et al., 2009). Larger studies of boys with cryptorchidism may 193 
indicate whether AGD measurements sub-divided according to congenital versus acquired forms reflect 194 
altered androgen action occurring in utero or during the early postnatal period.  195 
 196 
Gender-typical behaviour 197 
A relationship between prenatal androgen exposure and gender-related behaviour is well established in 198 
animals and humans (Hines et al., 2015). The evidence to support this in humans is mainly derived from 199 
studies of girls with congenital adrenal hyperplasia (CAH) who have been exposed to higher androgen levels 200 
during intrauterine life. Females with CAH show greater preference for boys’ toys and activities during 201 
childhood, have lower heterosexual orientation and are less feminine in their gender identity (Berenbaum and 202 
Hines, 1992; Hines et al., 2004; Pasterski et al., 2011; Pasterski et al., 2007; Pasterski et al., 2005). In 203 
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addition, androgen production during early infancy, as measured by urinary testosterone levels, is related to 204 
increased masculine play behaviour in healthy boys at 14 months of age (Lamminmaki et al., 2012). It is not 205 
clear, however, whether the observation is solely related to postnatal androgen exposure. We studied gender-206 
typed play behavior in healthy boys at age 3-4 years (n=81) in relation to longitudinal measurements of AGD 207 
and penile length during their first two years of life (Pasterski et al., 2015). Gender- related play behaviour 208 
was evaluated using the ‘Preschool Activities Inventory’ which consists of a validated 24-item parent 209 
questionnaire that assesses gender-typed toy and activity preferences (Golombok and Rust, 1993). Both AGD 210 
at birth, and penile growth during the first 3 months of life, independently predicted masculine behavior in a 211 
regression model controlling for overall changes in body size. As expected, AGD was not related to gender 212 
type play behaviour in girls. These findings provide evidence that AGD in healthy boys at birth reflects 213 
prenatal androgen exposure, whereas the rate of penile growth in early infancy reflects more the effect of early 214 
postnatal androgen exposure during mini-puberty. Taken together, both parameters have potential use as 215 
biomarkers of endocrine disruption during pre- and early post-natal development.  216 
 217 
Disorders of sex development (DSD) 218 
Disorders of sex development are defined as congenital conditions in which development of chromosomal, 219 
gonadal, or anatomical sex is atypical and include several disorders with well-defined alterations in production 220 
or action of sex steroids (Hughes et al., 2006). Although such presentations provide opportunities to study 221 
AGD as part of a phenotype, there are difficulties in identifying the landmarks for measurement of AGD, 222 
particularly in the in severe forms where there are genital ambiguities. An increased AGD has been reported 223 
in a small study of girls with CAH (Callegari et al., 1987). The complete form of androgen insensitivity 224 
syndrome (CAIS) is an example of XY sex reversal due to mutations in the androgen receptor gene resulting 225 
in resistance to androgen action (Hughes et al., 2012). As expected, an androgen receptor knock-out mouse 226 
model (the ARKO mouse) showed a female phenotype in ARKO males, including AGD similar to female 227 
mice (Yeh et al., 2002). No data are available for AGD in women with CAIS using the commonly used 228 
method of measurement discussed in this review. However, in a heterogenous group of 19 women with a 229 
clinical diagnosis of CAIS examined during a routine clinic visit, clitoral length was reduced but the clitoral to 230 
urethral distance (measured from the base of the clitoris to the anterior aspect of the external urethral meatus) 231 
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was similar to a control group of women undergoing a gynaecological examination under anaesthesia (Crouch 232 
et al., 2011). It is not clear whether the segment of perineum represented by this measurement truly reflects 233 
the AGD parameter which is accepted as being androgen dependent in both animal models and humans. 234 
Studies are required in the partial form of androgen insensitivity syndrome (PAIS) or hypogonadotrophic 235 
hypogonadism (where impaired androgen production occurs in late gestation) to determine if these, and other 236 
examples of DSD, provide information on assessing AGD as a quantitative measure of prenatal androgen 237 
exposure. Female rhesus monkeys exposed to androgens early in gestation exhibited hyperandrogenism, 238 
oligomenorrhea, large polyfollicular ovaries and other features consistent with the polycystic ovarian disease 239 
(PCOS) phenotype seen in humans (Abbott et al., 2005). The effects of such exposure in utero to higher 240 
androgens on AGD in female offspring of mothers with conditions such as CAH or PCOS merit study. A 241 
cross-sectional study of healthy young women showed greater follicular numbers were associated with longer 242 
AGD which, in turn, was also positively associated with higher serum testosterone levels (Mendiola et al., 243 
2012; Mira-Escolano et al., 2014). 244 
 245 
Testis function in adults and AGD 246 
Evidence has been accumulating in several countries since it was first reported that sperm quality in men is in 247 
decline (Carlsen et al., 1992). Impaired semen quality, an important marker of testis function and component 248 
of TDS, is now reported in up to 20% of otherwise healthy young men (Andersson et al., 2008; Jorgensen et 249 
al., 2006). Shorter AGD is associated with lower sperm concentration, total sperm count, sperm motility and 250 
also testosterone levels in men attending andrology clinics (Eisenberg et al., 2011; Eisenberg and Lipshultz, 251 
2015; Eisenberg et al., 2012; Mendiola et al., 2015). While a longer AGD is associated with a higher sperm 252 
count and better semen quality, the strength of association is insufficient to predict male fertility in an 253 
individual (Eisenberg and Lipshultz, 2015). A short AGD does distinguish men with non-obstructive causes of 254 
azoospermia (which is associated with TDS) from those with obstructive azoospermia (Eisenberg et al., 2012). 255 
These findings lend support for AGD as a biomarker for TDS and testis function in selected populations, but, 256 
few studies have explored the link between AGD and the larger range in testis size and semen quality in 257 
healthy males. A shorter AGD in association with lower semen quality has been reported in a US study of 258 
healthy young men (Mendiola et al., 2011); however, the results were not replicated in a similar study 259 
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conducted in Spanish population (Parra et al., 2015). Report of a lower AGD measured from the anus to the 260 
anterior penile base in patients with prostate cancer compared to men with other causes of lower urinary tract 261 
symptoms (Castaño-Vinyals et al., 2012) suggest a possible link between alterations in the androgen-262 
dependent fetal development of prostate (Wilson, 2011) and the cancer risk. However, anoscrotal distances 263 
were not different, and the findings of this small study need to be confirmed in future studies.  264 
 265 
Although testis function is a key component of TDS, it relationship with AGD in adults is somewhat 266 
conflicting. Whereas studies in selected groups of men attending andrology clinics showed consistent 267 
associations between shorter AGD and lower semen quality or testosterone levels (Eisenberg et al., 2011; 268 
Eisenberg and Lipshultz, 2015; Eisenberg et al., 2012; Mendiola et al., 2015), these relations were inconsistent 269 
in healthy men with only one of the two studies showing an association with semen quality and none showed a 270 
relationship with testosterone levels (Mendiola et al., 2011; Parra et al., 2015). We speculate that the link 271 
between AGD and testis function is more robust in adults at the lower end of the distribution of reproductive 272 
health (possibly reflecting a high prevalence of testicular dysgenesis) compared to healthy men.  273 
 274 
Genetic variations and AGD 275 
As previously discussed, establishing a direct link between prenatal androgen exposure and AGD is difficult 276 
in humans, and the current evidence has relied mainly on data from observational epidemiological studies. 277 
Novel study designs using genes as instruments for causal inferences (i.e., Mendelian Randomisation) as has 278 
been applied to the study of cardiovascular disease (Thanassoulis, 2013) could provide additional strength to 279 
the evidence linking AGD and androgen exposure. Gene polymorphisms associated with TGCC, testosterone 280 
levels and male fertility and based on large genome-wide association studies (GWAS) are now available and 281 
may provide suitable instruments to test this hypothesis (Kosova et al., 2012; Litchfield et al., 2015; Ruth et 282 
al., 2015). A similar approach on the basis of candidate gene analysis has found a variant in the estrogen 283 
receptor alpha gene (ESR1) associated with shorter AGD (Sathyanarayana et al., 2012). Polymorphisms in 284 
ESR1 are associated with hypospadias, male infertility and alterations in semen parameters (Ban et al., 2008; 285 
Safarinejad et al., 2010). Measurement of the number of CAG repeats in the androgen receptor gene (AR) in a 286 
cohort of adult males attending a urology clinic showed that increased CAG lengths were associated with 287 
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shorter AGD when the data were analysed in a stratified model (Eisenberg et al., 2013), but this finding was 288 
not replicated in another study (Sathyanarayana et al., 2012). There is an inverse association between the 289 
length of the CAG repeats and transcriptional activity of the androgen receptor as measured in vitro 290 
(Chamberlain et al., 1994), and when studied in relation to sperm quality, longer CAG repeats were associated 291 
with reduced sperm quality in some studies (Milatiner et al., 2004; Wallerand et al., 2001) but not in others 292 
(Dadze et al., 2000; Singh et al., 2006).  293 
 294 
Conclusion 295 
 There is considerable observational evidence in humans that supports a link between AGD and exposure to 296 
androgens during fetal life. The findings are consistent with animal data that show a critical MPW during fetal 297 
male sex development and the programming of AGD. A plethora of studies are now reporting population data 298 
for AGD and applying the methods to assess testicular function and androgen action across a wide range of 299 
clinical disorders. AGD also appears to be a valid biomarker to assess the effects of an adverse environment 300 
on human reproductive development from fetal to adult life. Gathering such information will rely on 301 
epidemiological studies of birth cohorts followed longitudinally with detailed anthropometric measurements 302 
and analysis of targeted chemicals in appropriate biological samples.  303 
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Table-1 Normative data for anogenital Distance (mm) at birth showing gender differences 
 
 
Means±SD or medians (range); The measurements correspond to the anoscrotal distance in boys and 
anofourchettal distance in girls. * studies reporting measurements in both genders at birth are included in the 
table 
Reference* Country n Male Female 
Male: Female 
Ratio 
Salazar-Martinez et al., 2004 Mexico 87 21±3 11±2 1.9 
Thankamony et al., 2009 UK 564 19.8±6.1 9.1±2.8 2.2 
Huang et al., 2009 Taiwan 65 23 (10-36) 16 (7-23) 1.4 
Sathyanarayana et al., 2010 USA 169 23±4 15±3 1.5 
Papadopoulou et al., 2013 Greece 165 27.1±4.4 14.4±3.0 1.9 
Papadopoulou et al., 2013 Spain 187 23.6±5.1 13.8±2.5 1.7 
Sathyanarayana et al., 2015 USA 758 24.7±4.5 16.0±3.2 1.5 
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Fig. 2 Longitudinal measurements of AGD in males (n=463) and females (n=426) from birth to 2 years of 
age. Data presented as means and error bars represent 95% Confidence Intervals. Reproduced with 
permission from EHP (Thankamony et al., 2009).  
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